JPMorgan Chase & Co. Raises Position in AngioDynamics, Inc. (ANGO)

JPMorgan Chase & Co. boosted its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 34.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 104,861 shares of the medical instruments supplier’s stock after buying an additional 26,761 shares during the quarter. JPMorgan Chase & Co.’s holdings in AngioDynamics were worth $1,709,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. SG Americas Securities LLC purchased a new position in AngioDynamics in the 3rd quarter valued at about $143,000. Acrospire Investment Management LLC lifted its stake in AngioDynamics by 3.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 8,915 shares of the medical instruments supplier’s stock valued at $145,000 after buying an additional 317 shares in the last quarter. Teachers Retirement System of The State of Kentucky lifted its stake in AngioDynamics by 54.9% in the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 11,000 shares of the medical instruments supplier’s stock valued at $178,000 after buying an additional 3,900 shares in the last quarter. BNP Paribas Arbitrage SA lifted its stake in AngioDynamics by 49.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 14,135 shares of the medical instruments supplier’s stock valued at $229,000 after buying an additional 4,668 shares in the last quarter. Finally, Arizona State Retirement System lifted its stake in AngioDynamics by 7.2% in the 2nd quarter. Arizona State Retirement System now owns 17,796 shares of the medical instruments supplier’s stock valued at $288,000 after buying an additional 1,200 shares in the last quarter. 95.23% of the stock is currently owned by hedge funds and other institutional investors.

AngioDynamics, Inc. (ANGO) opened at $16.40 on Wednesday. The company has a quick ratio of 1.65, a current ratio of 2.56 and a debt-to-equity ratio of 0.17. AngioDynamics, Inc. has a 12 month low of $14.80 and a 12 month high of $18.85. The firm has a market cap of $611.32, a P/E ratio of -60.74, a price-to-earnings-growth ratio of 1.57 and a beta of 1.04.

AngioDynamics (NASDAQ:ANGO) last released its earnings results on Thursday, January 4th. The medical instruments supplier reported $0.16 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.16. AngioDynamics had a negative net margin of 2.27% and a positive return on equity of 4.63%. The business had revenue of $86.70 million for the quarter, compared to analyst estimates of $88.15 million. During the same period last year, the company posted $0.19 EPS. The business’s revenue was down 2.6% on a year-over-year basis. sell-side analysts predict that AngioDynamics, Inc. will post 0.68 earnings per share for the current fiscal year.

A number of brokerages recently weighed in on ANGO. Craig Hallum lowered shares of AngioDynamics from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Zacks Investment Research raised shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Monday. TheStreet lowered shares of AngioDynamics from a “b-” rating to a “c” rating in a research note on Tuesday, January 2nd. KeyCorp reissued a “hold” rating on shares of AngioDynamics in a research note on Friday, September 29th. Finally, BidaskClub lowered shares of AngioDynamics from a “hold” rating to a “sell” rating in a research note on Saturday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $18.40.

COPYRIGHT VIOLATION NOTICE: “JPMorgan Chase & Co. Raises Position in AngioDynamics, Inc. (ANGO)” was reported by Markets Daily and is owned by of Markets Daily. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2018/01/10/jpmorgan-chase-co-raises-position-in-angiodynamics-inc-ango.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply